159 related articles for article (PubMed ID: 23066153)
1. The tumor suppressor CYLD controls the function of murine regulatory T cells.
Reissig S; Hövelmeyer N; Weigmann B; Nikolaev A; Kalt B; Wunderlich TF; Hahn M; Neurath MF; Waisman A
J Immunol; 2012 Nov; 189(10):4770-6. PubMed ID: 23066153
[TBL] [Abstract][Full Text] [Related]
2. Mutated cylindromatosis gene affects the functional state of dendritic cells.
Bros M; Dexheimer N; Besche V; Masri J; Trojandt S; Hövelmeyer N; Reissig S; Massoumi R; Grabbe S; Waisman A; Reske-Kunz AB
Eur J Immunol; 2010 Oct; 40(10):2848-57. PubMed ID: 20836156
[TBL] [Abstract][Full Text] [Related]
3. Differential requirement of IKK2 for CYLD-dependent representation of thymic and peripheral T-cell populations.
Tsagaratou A; Grammenoudi S; Mosialos G
Eur J Immunol; 2011 Oct; 41(10):3054-62. PubMed ID: 21728169
[TBL] [Abstract][Full Text] [Related]
4. Thymocyte-specific truncation of the deubiquitinating domain of CYLD impairs positive selection in a NF-kappaB essential modulator-dependent manner.
Tsagaratou A; Trompouki E; Grammenoudi S; Kontoyiannis DL; Mosialos G
J Immunol; 2010 Aug; 185(4):2032-43. PubMed ID: 20644164
[TBL] [Abstract][Full Text] [Related]
5. Impaired regulation of NF-kappaB and increased susceptibility to colitis-associated tumorigenesis in CYLD-deficient mice.
Zhang J; Stirling B; Temmerman ST; Ma CA; Fuss IJ; Derry JM; Jain A
J Clin Invest; 2006 Nov; 116(11):3042-9. PubMed ID: 17053834
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of CYLD as a trigger for NF-κB activation and a mechanism of apoptotic resistance in hepatocellular carcinoma cells.
Urbanik T; Köhler BC; Boger RJ; Wörns MA; Heeger S; Otto G; Hövelmeyer N; Galle PR; Schuchmann M; Waisman A; Schulze-Bergkamen H
Int J Oncol; 2011 Jan; 38(1):121-31. PubMed ID: 21109933
[TBL] [Abstract][Full Text] [Related]
7. Expression of CYLD, NF-kappaB and NF-kappaB-related factors in salivary gland tumors.
Fukuda M; Fukuda F; Horiuchi Y; Oku Y; Suzuki S; Kusama K; Sakashita H
In Vivo; 2006; 20(4):467-72. PubMed ID: 16900776
[TBL] [Abstract][Full Text] [Related]
8. Protective dendritic cell responses against listeriosis induced by the short form of the deubiquitinating enzyme CYLD are inhibited by full-length CYLD.
Wurm R; Just S; Wang X; Wex K; Schmid U; Blanchard N; Waisman A; Schild HJ; Deckert M; Naumann M; Schlüter D; Nishanth G
Eur J Immunol; 2015 May; 45(5):1366-76. PubMed ID: 25675948
[TBL] [Abstract][Full Text] [Related]
9. Expression of tumor necrosis factor-α induced protein 8 like-2 contributes to the immunosuppressive property of CD4(+)CD25(+) regulatory T cells in mice.
Luan YY; Yao YM; Zhang L; Dong N; Zhang QH; Yu Y; Sheng ZY
Mol Immunol; 2011 Oct; 49(1-2):219-26. PubMed ID: 21963221
[TBL] [Abstract][Full Text] [Related]
10. Liver specific deletion of CYLDexon7/8 induces severe biliary damage, fibrosis and increases hepatocarcinogenesis in mice.
Urbanik T; Boger RJ; Longerich T; Becker K; Ehrenberg KR; Hövelmeyer N; Hahn M; Schuchmann M; Jäger D; Waisman A; Wörns MA; Schulze-Bergkamen H
J Hepatol; 2012 Nov; 57(5):995-1003. PubMed ID: 22728872
[TBL] [Abstract][Full Text] [Related]
11. Loss of CYLD might be associated with development of salivary gland tumors.
Fukuda M; Hiroi M; Suzuki S; Ohmori Y; Sakashita H
Oncol Rep; 2008 Jun; 19(6):1421-7. PubMed ID: 18497946
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
[TBL] [Abstract][Full Text] [Related]
13. CTLA-4 (CD152) controls homeostasis and suppressive capacity of regulatory T cells in mice.
Kolar P; Knieke K; Hegel JK; Quandt D; Burmester GR; Hoff H; Brunner-Weinzierl MC
Arthritis Rheum; 2009 Jan; 60(1):123-32. PubMed ID: 19116935
[TBL] [Abstract][Full Text] [Related]
14. Cyld inhibits tumor cell proliferation by blocking Bcl-3-dependent NF-kappaB signaling.
Massoumi R; Chmielarska K; Hennecke K; Pfeifer A; Fässler R
Cell; 2006 May; 125(4):665-77. PubMed ID: 16713561
[TBL] [Abstract][Full Text] [Related]
15. CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members.
Trompouki E; Hatzivassiliou E; Tsichritzis T; Farmer H; Ashworth A; Mosialos G
Nature; 2003 Aug; 424(6950):793-6. PubMed ID: 12917689
[TBL] [Abstract][Full Text] [Related]
16. CARMA1 regulation of regulatory T cell development involves modulation of interleukin-2 receptor signaling.
Lee AJ; Wu X; Cheng H; Zhou X; Cheng X; Sun SC
J Biol Chem; 2010 May; 285(21):15696-703. PubMed ID: 20233721
[TBL] [Abstract][Full Text] [Related]
17. The deubiquitinase CYLD targets Smad7 protein to regulate transforming growth factor β (TGF-β) signaling and the development of regulatory T cells.
Zhao Y; Thornton AM; Kinney MC; Ma CA; Spinner JJ; Fuss IJ; Shevach EM; Jain A
J Biol Chem; 2011 Nov; 286(47):40520-30. PubMed ID: 21931165
[TBL] [Abstract][Full Text] [Related]
18. Regulation of B cell homeostasis and activation by the tumor suppressor gene CYLD.
Hövelmeyer N; Wunderlich FT; Massoumi R; Jakobsen CG; Song J; Wörns MA; Merkwirth C; Kovalenko A; Aumailley M; Strand D; Brüning JC; Galle PR; Wallach D; Fässler R; Waisman A
J Exp Med; 2007 Oct; 204(11):2615-27. PubMed ID: 17923499
[TBL] [Abstract][Full Text] [Related]
19. TNF activates a NF-kappaB-regulated cellular program in human CD45RA- regulatory T cells that modulates their suppressive function.
Nagar M; Jacob-Hirsch J; Vernitsky H; Berkun Y; Ben-Horin S; Amariglio N; Bank I; Kloog Y; Rechavi G; Goldstein I
J Immunol; 2010 Apr; 184(7):3570-81. PubMed ID: 20181891
[TBL] [Abstract][Full Text] [Related]
20. Naturally occurring short splice variant of CYLD positively regulates dendritic cell function.
Srokowski CC; Masri J; Hövelmeyer N; Krembel AK; Tertilt C; Strand D; Mahnke K; Massoumi R; Waisman A; Schild H
Blood; 2009 Jun; 113(23):5891-5. PubMed ID: 19342479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
